Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06567600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed
ClinicalTrials.gov study NCT02588443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00069875. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel
ClinicalTrials.gov study NCT00003540. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
ClinicalTrials.gov study NCT00006118. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
ClinicalTrials.gov study NCT02506842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT06532331. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01181245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
ClinicalTrials.gov study NCT00080795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
ClinicalTrials.gov study NCT01497392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00808145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00217282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer
ClinicalTrials.gov study NCT06156514. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.
ClinicalTrials.gov study NCT01929421. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Neg
ClinicalTrials.gov study NCT06026657. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00844688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT02283372. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer
ClinicalTrials.gov study NCT00102752. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
ClinicalTrials.gov study NCT05035147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT05852717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.